Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $6.70 (+47.6%) * Over Last 12-Mos
Rating Score: 2.3 / 10   Percentile Rank: 18%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/21/2025 Scotiabank Sung Ji Nam Downgrade Sector Perform
(Sector Outperform)		 6.00
(20.00)		 4.43
(4.54)		 2.48% Details
5/8/2025 Wolfe Research Doug Schenkel Downgrade Peerperform
(Outperform)		 N/A
(N/A)		 7.27
(4.54)		 -37.55% Details